Skip to content
10-K

Annual Report

COGNITION THERAPEUTICS INC CGTX

0001104659-26-034880

← back to feed
Filed
Mar 26, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 20, 2026 89.35M sh
Shares Diluted FY 2025 · Dec 31, 2025 72.77M sh
Shares Diluted FY 2025 · Dec 31, 2024 39.73M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$24.59M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$28.47M
Cash And Equivalents FY 2025 · Dec 31, 2025 $36.81M
Cash And Equivalents FY 2025 · Dec 31, 2024 $25.01M
Stockholders Equity FY 2025 · Dec 31, 2025 $34.27M
Stockholders Equity FY 2025 · Dec 31, 2024 $18.75M
Stockholders Equity FY 2025 · Dec 31, 2023 $24.47M
Current Liabilities FY 2025 · Dec 31, 2025 $13.92M
Current Liabilities FY 2025 · Dec 31, 2024 $11.14M
Total Liabilities FY 2025 · Dec 31, 2025 $14.12M
Total Liabilities FY 2025 · Dec 31, 2024 $11.48M
Current Assets FY 2025 · Dec 31, 2025 $47.99M
Current Assets FY 2025 · Dec 31, 2024 $29.56M
Total Assets FY 2025 · Dec 31, 2025 $48.39M
Total Assets FY 2025 · Dec 31, 2024 $30.23M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.32
Eps Diluted FY 2025 · Dec 31, 2024 −$0.86
Eps Basic FY 2025 · Dec 31, 2025 −$0.32
Eps Basic FY 2025 · Dec 31, 2024 −$0.86
Sga Expense FY 2025 · Dec 31, 2025 $10.61M
Sga Expense FY 2025 · Dec 31, 2024 $12.29M
Rd Expense FY 2025 · Dec 31, 2025 $37.19M
Rd Expense FY 2025 · Dec 31, 2024 $41.68M
Net Income FY 2025 · Dec 31, 2025 −$23.49M
Net Income FY 2025 · Dec 31, 2024 −$33.97M
Operating Income FY 2025 · Dec 31, 2025 −$47.8M
Operating Income FY 2025 · Dec 31, 2024 −$53.97M
Capex FY 2025 · Dec 31, 2024 $4K